Respiratory Disorders

The human respiratory system is a marvel of biological engineering, designed for efficient gas exchange. However, its constant interaction with the external environment makes it susceptible to a wide array of disorders.

These conditions can be broadly classified based on their primary impact (obstructive vs. restrictive), etiology (infectious, allergic, environmental, genetic), or duration (acute vs. chronic). For NEET aspirants, a detailed understanding of common respiratory disorders, their causes, symptoms, and basic pathophysiology is essential.

1. Asthma

Asthma is a chronic inflammatory disease of the airways, characterized by recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or in the early morning. These symptoms are usually associated with widespread, but variable, airflow obstruction within the lung that is often reversible either spontaneously or with treatment.

Etiology: — Often triggered by allergens (pollen, dust mites, pet dander), irritants (smoke, pollution, cold air), exercise, infections, or stress. Genetic predisposition plays a significant role.
Pathophysiology: — Exposure to a trigger in a susceptible individual leads to an immune response, primarily involving IgE antibodies and mast cells. This causes inflammation, bronchoconstriction (narrowing of airways due to smooth muscle contraction), and excessive mucus production, all contributing to airflow obstruction.
Symptoms: — Wheezing (a high-pitched whistling sound during breathing), dyspnea (shortness of breath), chest tightness, and cough.
Diagnosis: — Based on clinical history, physical examination, and lung function tests like spirometry, which shows reversible airflow obstruction (e.g., significant improvement in FEV1 after bronchodilator administration).
Management Principles: — Avoidance of triggers, bronchodilators (e.g., salbutamol) for quick relief, and anti-inflammatory medications (e.g., inhaled corticosteroids) for long-term control.

2. Emphysema

Emphysema is a chronic, progressive lung disease characterized by the irreversible enlargement of airspaces distal to the terminal bronchioles, accompanied by destruction of their walls without obvious fibrosis. It is a major component of Chronic Obstructive Pulmonary Disease (COPD).

Etiology: — The overwhelming cause is long-term exposure to cigarette smoke. Other factors include exposure to air pollution, occupational dusts and chemicals, and a rare genetic deficiency of alpha-1 antitrypsin.
Pathophysiology: — Noxious particles (like those in cigarette smoke) trigger an inflammatory response in the lungs. This leads to an imbalance between proteases (enzymes that break down proteins) and anti-proteases. The proteases, particularly elastase, destroy the elastic fibers in the alveolar walls, leading to their breakdown and the formation of large, inefficient air sacs (bullae). This reduces the surface area for gas exchange and traps air, making exhalation difficult.
Symptoms: — Progressive dyspnea (initially only on exertion, later at rest), chronic cough (often minimal compared to chronic bronchitis), weight loss, and characteristic 'pink puffer' appearance (due to hyperventilation and relatively normal blood oxygen levels until late stages).
Diagnosis: — Clinical history (especially smoking), physical exam (barrel chest, diminished breath sounds), and spirometry showing irreversible airflow obstruction (reduced FEV1/FVC ratio). Chest X-ray and CT scan can show hyperinflation and bullae.
Management Principles: — Smoking cessation is paramount. Bronchodilators, oxygen therapy, pulmonary rehabilitation, and in severe cases, lung volume reduction surgery or lung transplantation.

3. Chronic Bronchitis

Chronic bronchitis is defined clinically as a chronic productive cough for at least three months in two consecutive years, in the absence of other diseases that could explain the cough. It is also a major component of COPD.

Etiology: — Primarily caused by long-term exposure to irritants, most commonly cigarette smoke. Air pollution and occupational dusts also contribute.
Pathophysiology: — Chronic irritation of the bronchial lining leads to inflammation, hypertrophy of mucus-secreting glands, and increased mucus production. The cilia (tiny hair-like structures that clear mucus) are damaged, impairing mucociliary clearance. This results in chronic cough, sputum production, and increased susceptibility to infections. Airway narrowing can also occur due to inflammation and mucus plugging.
Symptoms: — Persistent productive cough with sputum, dyspnea (often later than cough), and frequent respiratory infections. Patients are often described as 'blue bloaters' due to hypoxemia and cyanosis.
Diagnosis: — Clinical definition (chronic productive cough), physical exam, and spirometry showing airflow obstruction.
Management Principles: — Smoking cessation, bronchodilators, corticosteroids (inhaled or oral during exacerbations), antibiotics for infections, and pulmonary rehabilitation.

4. Occupational Respiratory Disorders

These are lung diseases caused by exposure to harmful substances in the workplace.

Silicosis: — Caused by inhalation of crystalline silica dust (e.g., in mining, quarrying, sandblasting). Silica particles cause inflammation and progressive fibrosis (scarring) in the lungs, leading to restrictive lung disease. Symptoms include dyspnea, cough, and increased susceptibility to tuberculosis.
Asbestosis: — Caused by inhalation of asbestos fibers (e.g., in construction, shipbuilding). Asbestos fibers cause diffuse interstitial fibrosis. Symptoms include progressive dyspnea, cough, and chest pain. It also increases the risk of lung cancer and mesothelioma (a rare cancer of the pleura).
Byssinosis (Cotton Worker's Lung): — Caused by inhalation of cotton dust. Symptoms include chest tightness and dyspnea, typically worse on the first day of the work week.
Hypersensitivity Pneumonitis (Extrinsic Allergic Alveolitis): — An immune-mediated inflammatory lung disease caused by repeated inhalation of organic dusts (e.g., moldy hay in 'farmer's lung', bird droppings in 'bird fancier's lung'). It can cause acute, subacute, or chronic symptoms including fever, chills, cough, and dyspnea.
Prevention: — Strict workplace safety regulations, personal protective equipment (PPE), and regular health monitoring are crucial.

5. Pneumonia

Pneumonia is an acute inflammatory condition of the lung parenchyma (alveoli and bronchioles) caused by infection.

Etiology: — Most commonly caused by bacteria (e.g., Streptococcus pneumoniae, Haemophilus influenzae), viruses (e.g., influenza, RSV, SARS-CoV-2), fungi, or other microorganisms. Aspiration of food or gastric contents can also cause pneumonia.
Pathophysiology: — Pathogens enter the lungs, multiply, and trigger an inflammatory response. This leads to fluid and immune cells filling the alveoli, impairing gas exchange. The affected lung tissue becomes consolidated (solidified).
Symptoms: — Fever, chills, cough (often productive with colored sputum), dyspnea, pleuritic chest pain (sharp pain worsened by breathing), fatigue. Severity varies widely.
Diagnosis: — Clinical symptoms, physical exam (crackles, diminished breath sounds), chest X-ray showing infiltrates/consolidation, sputum culture, blood tests.
Management Principles: — Antibiotics for bacterial pneumonia, antivirals for viral pneumonia (if available), oxygen therapy, pain relief, and supportive care.

6. Tuberculosis (TB)

TB is a chronic infectious disease primarily affecting the lungs, caused by the bacterium Mycobacterium tuberculosis.

Etiology: — Inhalation of airborne droplets containing M. tuberculosis from an infected person. Risk factors include immunocompromised states (HIV/AIDS, malnutrition), close contact with infected individuals, and poor living conditions.
Pathophysiology: — Bacteria are phagocytosed by alveolar macrophages but survive and multiply within them. This triggers a cell-mediated immune response, forming granulomas (tubercles) to wall off the infection. Primary infection is often asymptomatic. If the immune system fails to contain the bacteria, it can reactivate (secondary TB) or disseminate to other organs (extrapulmonary TB).
Symptoms: — Chronic cough (often productive, sometimes with blood), fever (especially low-grade in the evening), night sweats, weight loss, fatigue, chest pain.
Diagnosis: — Sputum smear microscopy (for acid-fast bacilli), sputum culture, molecular tests (e.g., GeneXpert), chest X-ray (showing infiltrates, cavities), tuberculin skin test (Mantoux test), IGRA (interferon-gamma release assay).
Management Principles: — Long-term multi-drug antibiotic therapy (e.g., RIPE regimen: Rifampicin, Isoniazid, Pyrazinamide, Ethambutol) for 6-9 months. Directly Observed Treatment, Short-course (DOTS) is a key strategy to ensure adherence.

7. Acute Respiratory Distress Syndrome (ARDS)

ARDS is a severe, life-threatening lung injury characterized by widespread inflammation in the lungs, leading to fluid accumulation in the alveoli (non-cardiogenic pulmonary edema) and severe hypoxemia.

Etiology: — Can be triggered by various direct (e.g., severe pneumonia, aspiration, near-drowning, lung contusion) or indirect (e.g., sepsis, severe trauma, pancreatitis, massive transfusions) insults.
Pathophysiology: — The initial injury causes damage to the alveolar-capillary membrane, increasing its permeability. This allows fluid, proteins, and inflammatory cells to leak into the alveoli, inactivating surfactant and causing alveolar collapse. This leads to severe ventilation-perfusion mismatch and profound hypoxemia.
Symptoms: — Rapid onset of severe dyspnea, tachypnea (rapid breathing), hypoxemia refractory to oxygen therapy, diffuse bilateral infiltrates on chest X-ray.
Diagnosis: — Based on clinical criteria (acute onset, bilateral infiltrates on chest imaging, severe hypoxemia, absence of heart failure as the primary cause).
Management Principles: — Primarily supportive care in an intensive care unit (ICU), including mechanical ventilation with lung-protective strategies, treatment of the underlying cause, and fluid management. There is no specific pharmacological cure.

Common Misconceptions:

Asthma is psychological: — While stress can trigger asthma symptoms, asthma is a physiological disease with underlying inflammation and airway hyperresponsiveness.
COPD is only for smokers: — While smoking is the leading cause, non-smokers can develop COPD due to genetic factors (e.g., alpha-1 antitrypsin deficiency) or exposure to biomass fuel smoke/pollution.
Tuberculosis is a disease of the past: — TB remains a major global health problem, especially with the rise of drug-resistant strains.

NEET-Specific Angle: Questions often focus on distinguishing between disorders based on symptoms (e.g., reversible vs. irreversible obstruction), identifying causative agents (e.g., M. tuberculosis), understanding the primary pathology (e.g., alveolar destruction in emphysema, bronchoconstriction in asthma), and knowing key diagnostic features or treatment principles. Emphasis is placed on the most common and impactful disorders.